Monte Rosa Therapeutics Inc - GLUE - stock price prediction, stock price target, analyst ratings from 8 analysts

Monte Rosa Therapeutics Inc has a share price target of US$ 34, revenue growth forecast of 80.5%, and profit growth estimate of 71.2% for FY25, based on top 8 analyst calls.